Ganymed Pharmaceuticals GmbH, based in Mainz, Germany, is a biopharmaceutical company focused on the development of innovative cancer therapies. The organization specializes in the discovery and advancement of monoclonal antibodies targeting specific tumor antigens, aiming to enhance the efficacy and safety of cancer treatments. Ganymed's research is centered on precision medicine, leveraging advanced technologies to create targeted therapies that address unmet medical needs in oncology.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

10 Patents

#21 in Mainz

#3,755 in Germany

#56,092 in the World

Mainz, Germany

Ganymed Pharmaceuticals Gmbh

Forward Citations = 15

30 inventors:

Ugur Sahin (10 out of 196 patents)

Korden Walter (6 out of 18 patents)

Michael Koslowski (6 out of 53 patents)

4. Özlem Türeci (5 out of 53 patents)

5. Stefan Woll (5 out of 16 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Ganymed Pharmaceuticals Gmbh. Retrieved from https://idiyas.com/company/ganymed-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

15 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]